Literature DB >> 16322541

Mammalian egg activation: from Ca2+ spiking to cell cycle progression.

Keith T Jones1.   

Abstract

Mammalian eggs arrest at metaphase of the second meiotic division (MetII). Sperm break this arrest by inducing a series of Ca(2+) spikes that last for several hours. During this time cell cycle resumption is induced, sister chromatids undergo anaphase and the second polar body is extruded. This is followed by decondensation of the chromatin and the formation of pronuclei. Ca(2+) spiking is both the necessary and solely sufficient sperm signal to induce full egg activation. How MetII arrest is established, how the Ca(2+) spiking is induced and how the signal is transduced into cell cycle resumption are the topics of this review. Although the roles of most components of the signal transduction pathway remain to be fully investigated, here I present a model in which a sperm-specific phospholipase C (PLCzeta) generates Ca(2+) spikes to activate calmodulin-dependent protein kinase II and so switch on the Anaphase-Promoting Complex/Cyclosome (APC/C). APC/C activation leads to securin and cyclin B1 degradation and in so doing allows sister chromatids to be segregated and to decondense.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322541     DOI: 10.1530/rep.1.00710

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  27 in total

1.  Better intracytoplasmic sperm injection without sperm membranes and acrosome.

Authors:  Eduardo R S Roldan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

2.  Loss of activity mutations in phospholipase C zeta (PLCζ) abolishes calcium oscillatory ability of human recombinant protein in mouse oocytes.

Authors:  Junaid Kashir; Celine Jones; Hoi Chang Lee; Katja Rietdorf; Dimitra Nikiforaki; Claire Durrans; Margarida Ruas; Sze Tian Tee; Bjorn Heindryckx; Antony Galione; Petra De Sutter; Rafael A Fissore; John Parrington; Kevin Coward
Journal:  Hum Reprod       Date:  2011-10-18       Impact factor: 6.918

3.  Essential role of protein phosphatase 2A in metaphase II arrest and activation of mouse eggs shown by okadaic acid, dominant negative protein phosphatase 2A, and FTY720.

Authors:  Heng-Yu Chang; Phoebe C Jennings; Jessica Stewart; Nicole M Verrills; Keith T Jones
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

4.  Prognostic value of triploid zygotes on intracytoplasmic sperm injection outcomes.

Authors:  Rita C S Figueira; Amanda S Setti; Daniela P A F Braga; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2011-07-30       Impact factor: 3.412

Review 5.  Developmental control of oocyte maturation and egg activation in metazoan models.

Authors:  Jessica R Von Stetina; Terry L Orr-Weaver
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

Review 6.  Biochemical alterations in the oocyte in support of early embryonic development.

Authors:  Jacinta H Martin; Elizabeth G Bromfield; R John Aitken; Brett Nixon
Journal:  Cell Mol Life Sci       Date:  2016-09-07       Impact factor: 9.261

7.  Cycling through mammalian meiosis: B-type cyclins in oocytes.

Authors:  Nora Bouftas; Katja Wassmann
Journal:  Cell Cycle       Date:  2019-06-23       Impact factor: 4.534

8.  Maturation outcomes are improved following Cryoleaf vitrification of immature human oocytes when compared to choline-based slow-freezing.

Authors:  Catherine M H Combelles; S Temel Ceyhan; Haiyan Wang; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2011-11-17       Impact factor: 3.412

9.  Cdc25A activity is required for the metaphase II arrest in mouse oocytes.

Authors:  Jeong Su Oh; Andrej Susor; Karen Schindler; Richard M Schultz; Marco Conti
Journal:  J Cell Sci       Date:  2013-01-23       Impact factor: 5.285

10.  Sperm chromatin-induced ectopic polar body extrusion in mouse eggs after ICSI and delayed egg activation.

Authors:  Manqi Deng; Rong Li
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.